calendar
7,922 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 138 phase 2 completion · 64 phase 1 completion
next 91 dayslessmore
MonWedFri
7,922 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 138 phase 2 completion · 64 phase 1 completion
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02, 9.01
Items: 1.01, 9.01
Items: 5.02, 8.01, 9.01
Items: 8.01
Items: 1.01, 7.01, 9.01
Items: 3.01
Items: 5.02, 9.01
Items: 3.01, 9.01
Items: 7.01, 9.01
Items: 5.02
Items: 5.07
Items: 5.02
Items: 5.07
Items: 1.01, 5.01, 7.01, 9.01
Items: 5.02
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 5.02
Items: 7.01, 9.01
Items: 1.01, 9.01
Items: 7.01, 9.01
Items: 1.02, 8.01
Items: 5.02
Items: 3.01, 8.01, 9.01
Items: 3.01
Items: 3.01
Items: 3.02, 8.01, 9.01
Items: 1.01, 2.01, 2.03, 9.01
Items: 1.02
Items: 5.08, 8.01
Items: 5.07
Items: 1.01, 1.02, 3.02, 9.01
Items: 3.01
Items: 3.01
Items: 8.01, 9.01
Items: 3.01, 8.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 3.02, 5.03, 5.07, 9.01
Items: 7.01
action date of January 4, 2027
action date of Jan. 21, 2027
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain
Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain
Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Unresectable Melanoma